A. Zoubek
About
A. Zoubek is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, A. Zoubek has authored 101 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 20 papers in Pathology and Forensic Medicine and 18 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A. Zoubek's work include Sarcoma Diagnosis and Treatment (52 papers), Cardiac tumors and thrombi (18 papers) and Lymphoma Diagnosis and Treatment (16 papers). A. Zoubek is often cited by papers focused on Sarcoma Diagnosis and Treatment (52 papers), Cardiac tumors and thrombi (18 papers) and Lymphoma Diagnosis and Treatment (16 papers). A. Zoubek collaborates with scholars based in Austria, Germany and United States. A. Zoubek's co-authors include Heribert Jürgens, Stefan Bielack, R. Kotz, Winfried Winkelmann, Beate Kempf‐Bielack, Helmut Gadner, M. Salzer‐Kuntschik, G. Ulrich Exner, Silke Flege and K. Helmke and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.
In The Last Decade
A. Zoubek
95 papers receiving 6.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| A. Zoubek Austria | 35 | 4.7k | 1.6k | 1.6k | 1.6k | 1.2k | 101 | 6.6k | ||
| Leonard H. Wexler United States | 48 | 4.2k 0.9× | 1.3k 0.8× | 2.2k 1.3× | 1.3k 0.8× | 1.1k 0.9× | 159 | 7.6k | ||
| Allen M. Goorin United States | 37 | 3.4k 0.7× | 1.1k 0.7× | 2.0k 1.3× | 1.2k 0.8× | 986 0.8× | 56 | 6.2k | ||
| Alessandra Longhi Italy | 47 | 5.4k 1.2× | 1.5k 0.9× | 2.0k 1.2× | 2.9k 1.8× | 1.6k 1.3× | 174 | 7.4k | ||
| Gaetano Bacci Italy | 51 | 6.3k 1.4× | 1.7k 1.0× | 2.4k 1.5× | 3.1k 1.9× | 2.0k 1.7× | 123 | 8.7k | ||
| Stefano Ferrari Italy | 56 | 7.3k 1.6× | 2.0k 1.2× | 2.8k 1.7× | 3.5k 2.2× | 2.0k 1.6× | 206 | 10.0k | ||
| Teresa J. Vietti United States | 43 | 4.6k 1.0× | 1.4k 0.9× | 2.2k 1.4× | 1.6k 1.0× | 1.9k 1.5× | 149 | 8.0k | ||
| H. Jürgens Germany | 40 | 3.4k 0.7× | 851 0.5× | 1.1k 0.7× | 1.2k 0.8× | 1.2k 1.0× | 138 | 5.4k | ||
| Sant P. Chawla United States | 50 | 5.4k 1.1× | 1.9k 1.2× | 3.9k 2.4× | 2.3k 1.5× | 1.4k 1.2× | 300 | 9.7k | ||
| Mario Mercuri Italy | 51 | 5.2k 1.1× | 1.2k 0.7× | 1.5k 0.9× | 2.9k 1.8× | 2.9k 2.4× | 120 | 7.9k | ||
| Scott H. Okuno United States | 42 | 3.6k 0.8× | 959 0.6× | 2.5k 1.6× | 738 0.5× | 1.2k 1.0× | 178 | 5.8k |
Countries citing papers authored by A. Zoubek
Since
Specialization
Citations
This map shows the geographic impact of A. Zoubek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Zoubek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Zoubek more than expected).
Fields of papers citing papers by A. Zoubek
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by A. Zoubek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Zoubek. The network helps show where A. Zoubek may publish in the future.
Co-authorship network of co-authors of A. Zoubek
This figure shows the co-authorship network connecting the top 25 collaborators of A. Zoubek. A scholar is included among the top collaborators of A. Zoubek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Zoubek. A. Zoubek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bielack, Stefan, Beate Kempf‐Bielack, G. Delling, et al.. (2023). Prognostic Factors in High-Grade Osteosarcoma of theExtremities or Trunk: An Analysis of 1,702 Patients Treatedon Neoadjuvant Cooperative Osteosarcoma Study GroupProtocols. Journal of Clinical Oncology. 41(27). 4323–4337.
2.
Bielack, Stefan, H. Jürgens, Gernot Jundt, et al.. (2009). Osteosarcoma: The COSS Experience. Cancer treatment and research. 152. 289–308.
3.
Bielack, Stefan, Beate Kempf‐Bielack, D. Branscheid, et al.. (2008). Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients. Journal of Clinical Oncology. 27(4). 557–565.
4.
Paulussen, Michael, Alan Craft, Ian Lewis, et al.. (2008). Results of the EICESS-92 Study: Two Randomized Trials of Ewing's Sarcoma Treatment—Cyclophosphamide Compared With Ifosfamide in Standard-Risk Patients and Assessment of Benefit of Etoposide Added to Standard Treatment in High-Risk Patients. Journal of Clinical Oncology. 26(27). 4385–4393.
5.
Steiner, M., Susanne Matthes‐Martin, Andishe Attarbaschi, et al.. (2007). Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosis. Haematologica. 92(1). e3–e4.
6.
Kager, Leo, A. Zoubek, Ulrike Kastner, et al.. (2006). Skip Metastases in Osteosarcoma: Experience of the Cooperative Osteosarcoma Study Group. Journal of Clinical Oncology. 24(10). 1535–1541.
7.
Furtwaengler, Rhoikos, Harald Reinhard, Ivo Leuschner, et al.. (2006). Mesoblastic nephroma—A report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH). Cancer. 106(10). 2275–2283.
8.
Gosheger, Georg, G. Delling, Wolfgang E. Berdel, et al.. (2005). Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma. Journal of Cancer Research and Clinical Oncology. 131(8). 520–526.
9.
Melton, RG, Carola Hasan, A. Zoubek, et al.. (2005). Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure. British Journal of Cancer. 92(3). 480–487.
10.
Paya, Kurosh, et al.. (2001). Bilateral Wilms' Tumor - Surgical Aspects. European Journal of Pediatric Surgery. 11(2). 99–104.
11.
Fischmeister, Gustav, Volker Witt, G. Fritsch, et al.. (2000). Permanent tunneled silicone central venous catheters for autologous PBPC harvest in children and young adults. Bone Marrow Transplantation. 26(7). 781–786.
12.
Fischmeister, Gustav, A. Zoubek, Dragana Jugović, et al.. (1999). Low incidence of molecular evidence for tumour in PBPC harvests from patients with high risk Ewing tumours. Bone Marrow Transplantation. 24(4). 405–409.
13.
Zoubek, A., Ruth Ladenstein, Rein hard Windhager, et al.. (1998). Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT-PCR: A preliminary evaluation. International Journal of Cancer. 79(1). 56–60.
14.
Kovar, Heinrich, Gunhild Jug, Dave N.T. Aryee, et al.. (1997). Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Oncogene. 15(18). 2225–2232.
15.
Fink, Franz‐Martin, G. Fritsch, Georg Mann, et al.. (1995). Recombinant human granulocyte‐macrophage colony‐stimulating factor in septic neutropenic pediatric cancer patients: Detection of circulating hematopoietic precursor cells correlates with rapid granulocyte recovery. Medical and Pediatric Oncology. 25(5). 365–371.
16.
Zoubek, A., Gerhard Mostbeck, L. Thun‐Hohenstein, et al.. (1995). Response of untreated stage IV Wilms' tumor to single dose carboplatin assessed by “up front” window therapy. Medical and Pediatric Oncology. 25(1). 8–11.
17.
Ladenstein, Ruth, Christian Urban, Helmut Gadner, et al.. (1995). First experience with prognostic factors in unselected neuroblastoma patients. The Austrian neuroblastoma 87 study. European Journal of Cancer. 31(4). 637–641.
18.
Zoubek, A., Georg Mann, Christina Peters, et al.. (1994). High-Dose Cyclophosphamide, Adriamycin, And Vlncrlstlne (Hd-Cav) In Children with Recurrent Solid Tumor. Pediatric Hematology and Oncology. 11(6). 613–623.
19.
Zoubek, A., Christa Pfleiderer, M. Salzer‐Kuntschik, et al.. (1994). Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data. British Journal of Cancer. 70(5). 908–913.
20.
Ambros, Inge M., Thomas Lion, Oskar A. Haas, et al.. (1994). Detection of numerical and structural chromosome abnormalities in pediatric germ cell tumors by means of interphase cytogenetics. Genes Chromosomes and Cancer. 11(1). 40–50.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Leonard H. Wexler Breakdown of academic impact, for papers by Allen M. Goorin Breakdown of academic impact, for papers by Alessandra Longhi Breakdown of academic impact, for papers by Gaetano Bacci Breakdown of academic impact, for papers by Stefano Ferrari Breakdown of academic impact, for papers by Teresa J. Vietti Breakdown of academic impact, for papers by H. Jürgens Breakdown of academic impact, for papers by Sant P. Chawla Breakdown of academic impact, for papers by Mario Mercuri Breakdown of academic impact, for papers by Scott H. Okuno